Loading...
•
Mar 31, 2024
OPKO Health Q1 2024 Earnings Report
OPKO Health's financial performance declined in Q1 2024, with increased operating and net losses, primarily due to decreased revenues and non-recurring expenses.
Key Takeaways
OPKO Health reported a decrease in total revenues to $173.7 million in Q1 2024 from $237.6 million in Q1 2023. The operating loss increased to $71.5 million from $30.6 million, and the net loss was $81.8 million, or $0.12 per share, compared to a net loss of $18.3 million, or $0.02 per share, in the prior year period. The company's cash and cash equivalents were $75.6 million as of March 31, 2024.
Total revenues decreased to $173.7 million compared to $237.6 million in the same period last year.
Operating loss increased to $71.5 million from $30.6 million year-over-year.
Net loss for the quarter was $81.8 million, or $0.12 per share, compared to a net loss of $18.3 million, or $0.02 per share, in the prior year period.
Cash and cash equivalents totaled $75.6 million as of March 31, 2024.
Revenue by Segment
Forward Guidance
OPKO Health's management will provide a business update, discuss first quarter financial results, provide financial guidance and answer questions during a conference call and live audio webcast today beginning at 4:30 p.m. Eastern time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...